A few years ago, when Virta Health founder and CEO Sami Inkinen approached employers about leveraging the company’s nutrition-oriented digital diabetes program for obesity-related weight loss, most companies weren’t ready to commit.
Now, more employers are all in on nutritional counseling and coaching as they grapple with rising costs for diabetes and weight loss drugs like Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepbound.
High-cost weight loss drugs boost nutrition counseling with employers
